Stock Market Reviews

Read and share opinions on CELZ (Creative Medical Technology Holdings, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance i

Latest News

• Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now
  Nov 5, 2025
• Market Sentiment Around Loss-Making Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ)
  Oct 31, 2025
• Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits
  Oct 30, 2025
• Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
  Oct 29, 2025
• Creative Medical Technology Holdings Issues Letter to Shareholders
  Oct 27, 2025
• Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs
  Oct 7, 2025
• Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
  Aug 13, 2025
• Creative Medical Technology Holdings Second Quarter 2025 Earnings: US$0.48 loss per share (vs US$1.11 loss in 2Q 2024)
  Aug 11, 2025
• New Strong Sell Stocks for July 31st
  Jul 31, 2025
• Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
  Jul 17, 2025
• Creative Medical Technology Holdings Receives Notice of Allowance for ImmCelz™ for Treatment of Heart Failure and/or Post Infarct Pathological Remodeling
  Jul 11, 2025
• Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
  Mar 20, 2025
• Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds
  Mar 6, 2025
• Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential
  Feb 20, 2025
• Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
  Feb 14, 2025
• Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
  Feb 11, 2025
• Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
  Feb 5, 2025
• Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
  Jan 30, 2025